COMMUNIQUÉS West-GlobeNewswire

AveXis Reports Fourth Quarter and Full Year 2017 Financial and Operating Results
27/02/2018
– On track to request pre-BLA meeting with FDA in Q2 2018 – – Intends to initiate pivotal trial in SMA Type 1 in Europe and multi-national pre-symptomatic SMA study in the first half of 2018 – – Anticipates IND [...]
Teladoc Announces Full Year and Fourth Quarter 2017 Results
27/02/2018
2017 Revenue of $233.3 million, growth of 89%; 4Q 2017 Revenue of $77.1 million, growth of 106% Total Paid Membership of 23.2 million, growth of 33% 2017 Visits of 1,463,000, growth of 54%; 4Q 2017 Visits of 464,000, [...]
Achaogen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
27/02/2018
-- Plazomicin New Drug Application (NDA) accepted by U.S. Food and Drug Administration (FDA); June 25, 2018 set as PDUFA action date -- -- Orally-administered antibacterial candidate C-Scape achieved positive top-line [...]
Atara Biotherapeutics Announces Proposed Offering of Common Stock
27/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]
Endocyte Appoints Patrick Machado, J.D. to Its Board of Directors
27/02/2018
– Patrick Machado, Co-founder and Former Chief Business and Financial Officer of Medivation, Brings Significant Experience in Building Value in the Prostate Cancer Space – WEST LAFAYETTE, Ind., Feb. 27, 2018 (GLOBE [...]
MannKind Corporation Reports 2017 Fourth Quarter and Full Year Financial Results
27/02/2018
Q4 and 2H 2017 Afrezza net revenue were $4.5 million (+238%) and $6.4 million (+240%) vs. 2016, respectively Q4 and 2H 2017 net cash used in operating activities were $30.0 million and $53.3 million, respectively Cash [...]
MacroGenics Provides Update on Corporate Progress and 2017 Financial Results
27/02/2018
ROCKVILLE, Md., Feb. 27, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2017 Corporate Update and Results
27/02/2018
CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced that it will host a conference call and webcast on Tuesday, March 6th, 2018, [...]
Amicus Therapeutics Launches Healing Beyond Disease™ Initiatives to Change People’s Lives Living with Rare Diseases
27/02/2018
CRANBURY, N.J., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) is honoring Rare Disease Day this week with the launch of Healing Beyond Disease™, a global, Amicus employee-driven initiative [...]
Gemphire Expert Panel Call on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) and NASH to be Rescheduled
27/02/2018
LIVONIA, Mich., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]
Pledge to #EndTheStigma on Mental Health with assessURhealth™ at HIMSS18
27/02/2018
Tampa, FL, Feb. 27, 2018 (GLOBE NEWSWIRE) -- assessURhealth, LLC brings its mental and behavioral health screening tool to the exhibit floor for the 2018 HIMSS Conference & Exhibition at the Sands Convention Center [...]
Adventist Health Selects Michelle Fuentes to Lead Adventist Health Sonora
27/02/2018
ROSEVILLE, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Adventist Health —a faith-based, nonprofit integrated health system serving more than 75 communities in California, Oregon and Hawaii—today announced the appointment [...]
Health Quality Council of Alberta seeks voice of Albertans to improve healthcare quality
27/02/2018
CALGARY, Alberta, Feb. 27, 2018 (GLOBE NEWSWIRE) -- The Health Quality Council of Alberta (HQCA) is looking for Albertans to join its Patient and Family Advisory Committee to bring the patient and family perspective to [...]
Atrion Corporation Declares Quarterly Cash Dividend
27/02/2018
ALLEN, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI ) today announced that its Board of Directors declared a quarterly dividend of $1.20 per share on its outstanding shares of Common Stock. [...]
Vital® to Showcase Enhancements to the Vitrea® Enterprise Imaging Solution at HIMSS 2018
27/02/2018
MINNETONKA, Minn., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Vital Images, Inc., will feature the latest developments within its powerful Vitrea Enterprise Imaging solution at HIMSS 2018, in booth 843, March 5-9, in Las Vegas, [...]
Micron Solutions, Inc. Announces Multi-Year Exclusive Manufacturing Agreement with its Largest Customer
27/02/2018
FITCHBURG, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (the “Company”) (NYSE American:MICR) is pleased to announce that its wholly owned subsidiary Micron Products, Inc. (“Micron”) with offices in [...]
Helsinn Group announces the appointment of Paul Rittman as Chief Executive Officer, Helsinn Therapeutics (HTU)
27/02/2018
Helsinn Group announces the appointment of Paul Rittman as Chief Executive Officer, Helsinn Therapeutics (HTU) Lugano, Switzerland February 27, 2018 - Helsinn, a Swiss pharmaceutical group focused on building quality [...]
Dentsply Sirona to Report Fourth Quarter and Fiscal 2017 Results
27/02/2018
YORK, Pa., Feb. 27, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company™, today announced that the Company will report fourth quarter and fiscal 2017 financial [...]
AllSpire Health GPO Adopts Lumere’s Solutions to Support Value-Based Initiatives
27/02/2018
CHICAGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- AllSpire Health GPO, LLC—a health system alliance created to escalate the improvement of clinical outcomes, enable greater access to affordable healthcare, ensure economic [...]

Pages